The interface of science, innovation, and imagination
It’s a dull, wet, and gloomy day here in the south east, as if the Gods have decided to channel a typical English summer across the pond, so rather than talk about shadows in the rain there’s a much more cheerful and colourful topic to discuss.
In our latest expert interview on the topic of AI and deep learning, we turn to a dynamic CEO with a different approach and a clear vision.
Much of this space has focused on the issues around training and validation sets as well as the inherent challenge with bias being projected where is isn’t wanted or needed.
What if… we could ask a machine to tell us what it sees instead?
A word of warning – this has absolutely nothing to do with IBM Watson – and everything to do with biology and drug development!
BSB subscribers can learn more about our latest interview in the AI/deep learning niche – you can read all about it by logging in or click to access our ongoing oncology analysis.
This content is restricted to subscribers